Compounded GLP-1 and dual GIP/GLP-1 receptor agonists: a Statement from the American Diabetes Association
Efficacy and Safety of Retatrutide, a Novel GLP-1, GIP, and Glucagon Receptor Agonist for Obesity Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Proceedings (Baylor University
Initial clinical assessment: Healthcare providers should obtain a detailed history including symptom onset, character, severity, and relationship to medication initiation or dose changes
This can be a convenient option if you need labs done quickly and can't get a prompt appointment at Quest or LabCorp
Due to the promotive effect of GLP-1R agonism on -cells proliferation and survival, concerns of tumorigenesis, especially pancreatic cancers, have been raised about incretin-based therapies (89)
Where Should You Inject a GLP1 Medication